Literature DB >> 2887886

Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.

A Ranki, S L Valle, M Krohn, J Antonen, J P Allain, M Leuther, G Franchini, K Krohn.   

Abstract

Signs of latent HIV infection were sought in stored serum samples collected before overt seroconversion, confirmed by enzyme-linked immunosorbent assay (ELISA), from 9 subjects with human-immunodeficiency-virus (HIV) infection, in serum from 25 seronegative sexual partners of HIV-seropositive men and from 23 other seronegative, homosexually active men. Free HIV antigen and/or low-titre antibodies to recombinant structural (core, env) or non-structural (3' orf, sor, tat) proteins were seen 6-14 months before seroconversion in all 9 subjects who seroconverted. Antibodies against core proteins detected by western blot were usually the first sign of latent HIV infection. 5 of the 25 ELISA-negative exposed partners have shown HIV antigenaemia and antibodies against core proteins for 16-34 months. By in-situ hybridisation, HIV-specific RNA was detected in peripheral-blood non-lymphoid mononuclear cells in some of the latently infected partners. All subjects with latent HIV infection had normal numbers of T4 lymphocytes but half of them lost their in-vitro proliferative T-cell response to a recall antigen (purified protein derivative of tuberculin). Early HIV infection, characterised by a low-level and restricted antibody response towards HIV core and regulatory proteins, seems mainly to affect antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887886     DOI: 10.1016/s0140-6736(87)92985-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  66 in total

Review 1.  Technology and effect: HIV/AIDS testing in Brazil.

Authors:  J Biehl; D Coutinho; A L Outeiro
Journal:  Cult Med Psychiatry       Date:  2001-03

2.  Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo.

Authors:  J A Mikovits; N C Lohrey; R Schulof; J Courtless; F W Ruscetti
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

Review 4.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

5.  Pharmacy education about HIV and condoms.

Authors:  P D Cleary; A M Brandt; L O Gostin; K Mayer; T Ronna; M Costanzo
Journal:  Am J Public Health       Date:  1990-11       Impact factor: 9.308

6.  HIV-2 antibody testing of blood donors with doubtful immunoblot results for HIV-1.

Authors:  J Knüver-Hopf; H Mohr; J Beyer; B Lambrecht; D Mix; H Rübsamen-Waigmann; H Schmitt
Journal:  Blut       Date:  1989-03

7.  Comparison of immunoblots with neutralizing and complement fixing antibodies in experimental and natural cases of visna-maedi.

Authors:  E G Torfason; M Gudnadóttir; A Löve
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Multicenter evaluation of the novel ABN Western blot (immunoblot) system in comparison with an enzyme-linked immunosorbent assay and a different Western blot.

Authors:  B Weber; G Hess; R Enzensberger; F Harms; C J Evans; A Hamann; H W Doerr
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

9.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

Authors:  G W Rutherford; A R Lifson; N A Hessol; W W Darrow; P M O'Malley; S P Buchbinder; J L Barnhart; T W Bodecker; L Cannon; L S Doll
Journal:  BMJ       Date:  1990-11-24

Review 10.  Clinical, virological and immunological features of primary HIV-1 infection.

Authors:  M D de Jong; H J Hulsebosch; J M Lange
Journal:  Genitourin Med       Date:  1991-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.